These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines. Waheed MT, Thönes N, Müller M, Hassan SW, Razavi NM, Lössl E, Kaul HP, Lössl AG. Transgenic Res; 2011 Apr; 20(2):271-82. PubMed ID: 20563641 [Abstract] [Full Text] [Related]
3. Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes. Waheed MT, Thönes N, Müller M, Hassan SW, Gottschamel J, Lössl E, Kaul HP, Lössl AG. Plant Biotechnol J; 2011 Aug; 9(6):651-60. PubMed ID: 21447051 [Abstract] [Full Text] [Related]
4. Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras. Pineo CB, Hitzeroth II, Rybicki EP. Plant Biotechnol J; 2013 Oct; 11(8):964-75. PubMed ID: 23924054 [Abstract] [Full Text] [Related]
5. An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice. Paz De la Rosa G, Monroy-García A, Mora-García Mde L, Peña CG, Hernández-Montes J, Weiss-Steider B, Gómez-Lim MA. Virol J; 2009 Jan 06; 6():2. PubMed ID: 19126233 [Abstract] [Full Text] [Related]
6. Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum. Kohl TO, Hitzeroth II, Christensen ND, Rybicki EP. BMC Biotechnol; 2007 Sep 12; 7():56. PubMed ID: 17850660 [Abstract] [Full Text] [Related]
7. Immunization with Human Papillomavirus 16 L1+E2 Chimeric Capsomers Elicits Cellular Immune Response and Antitumor Activity in a Mouse Model. López-Toledo G, Schädlich L, Alonso-Castro ÁJ, Monroy-García A, García-Rocha R, Guido MC, Gissmann L, García-Carrancá A. Viral Immunol; 2016 Jun 12; 29(5):276-87. PubMed ID: 27058179 [Abstract] [Full Text] [Related]
8. Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco. Lenzi P, Scotti N, Alagna F, Tornesello ML, Pompa A, Vitale A, De Stradis A, Monti L, Grillo S, Buonaguro FM, Maliga P, Cardi T. Transgenic Res; 2008 Dec 12; 17(6):1091-102. PubMed ID: 18491213 [Abstract] [Full Text] [Related]
10. Inducible expression of human papillomavirus-16 L1 capsomeres in the plastomes of Nicotiana tabacum: Transplastomic plants develop normal flowers and pollen. Latif S, Gottschamel J, Syed T, Younus I, Gull K, Sameeullah M, Batool N, Lössl AG, Mariz F, Müller M, Mirza B, Waheed MT. Biotechnol Appl Biochem; 2022 Apr 12; 69(2):596-611. PubMed ID: 33650709 [Abstract] [Full Text] [Related]
11. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic. Chen Y, Liu Y, Zhang G, Wang A, Dong Z, Qi Y, Wang J, Zhao B, Li N, Jiang M. Virus Res; 2016 Jul 15; 220():97-103. PubMed ID: 27107614 [Abstract] [Full Text] [Related]
13. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, Zosso N, Ponci F, Nardelli-Haefliger D. Clin Vaccine Immunol; 2007 Oct 15; 14(10):1285-95. PubMed ID: 17687110 [Abstract] [Full Text] [Related]
14. [Prokaryotic expression of HPV 16 L1 gene and identification of its immune activity]. Hao DF, Ma ZH, Wang YP, Rexidan, Zhang FC. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul 15; 21(4):428-31. PubMed ID: 15989783 [Abstract] [Full Text] [Related]
15. Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity. Schädlich L, Senger T, Kirschning CJ, Müller M, Gissmann L. Vaccine; 2009 Mar 04; 27(10):1511-22. PubMed ID: 19174177 [Abstract] [Full Text] [Related]
16. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. Sehr P, Müller M, Höpfl R, Widschwendter A, Pawlita M. J Virol Methods; 2002 Oct 04; 106(1):61-70. PubMed ID: 12367730 [Abstract] [Full Text] [Related]
17. Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection. Jagu S, Kwak K, Garcea RL, Roden RB. Vaccine; 2010 Jun 17; 28(28):4478-86. PubMed ID: 20434552 [Abstract] [Full Text] [Related]
18. Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice. Ohlschläger P, Osen W, Dell K, Faath S, Garcea RL, Jochmus I, Müller M, Pawlita M, Schäfer K, Sehr P, Staib C, Sutter G, Gissmann L. J Virol; 2003 Apr 17; 77(8):4635-45. PubMed ID: 12663770 [Abstract] [Full Text] [Related]
19. VLP Production from Recombinant L1/L2 HPV-16 Protein Expressed in Pichia Pastoris. Sanchooli A, Aghaiypour K, Kiasari BA, Samarbaf-Zadeh A, Ghadiri A, Makvandi M. Protein Pept Lett; 2018 Apr 17; 25(8):783-790. PubMed ID: 30091403 [Abstract] [Full Text] [Related]